$12.3B
$146 Million
8.93% of portfolio
1,160,425
Q2 2025
Reduced 2.64%
$2.24B
$113 Million
6.91% of portfolio
3,605,029
Q2 2025
Added 33.03%
$35.3B
$107 Million
6.57% of portfolio
194,491
Q2 2025
Added 20.92%
$3.69B
$100 Million
6.13% of portfolio
727,811
Q2 2025
Added 81.61%
$11B
$94 Million
5.76% of portfolio
496,730
Q2 2025
Reduced 6.37%
$6.19B
$90.2 Million
5.53% of portfolio
2,542,104
Q2 2025
Reduced 14.64%
$3.29B
$89.7 Million
5.49% of portfolio
1,175,876
Q2 2025
Added 39.83%
$846M
$68.3 Million
4.18% of portfolio
5,210,831
Q2 2025
Added 111.93%
$2.39B
$67.8 Million
4.15% of portfolio
522,410
Q2 2025
Added 72.75%
$4.25B
$62.3 Million
3.82% of portfolio
603,414
Q2 2025
Reduced 3.37%
$150B
$61.1 Million
3.74% of portfolio
309,339
Q1 2025
New
$187B
$54.8 Million
3.36% of portfolio
135,233
Q2 2025
Added 5.87%
$169B
$48.7 Million
2.98% of portfolio
89,600
Q2 2025
Added 1.82%
$4.87B
$46.2 Million
2.83% of portfolio
300,029
Q2 2025
Reduced 46.08%
$1.81B
$45 Million
2.76% of portfolio
3,863,107
Q2 2025
Reduced 19.58%
$5.63B
$43.6 Million
2.67% of portfolio
837,800
Q2 2025
Reduced 36.88%
$1.65B
$40.4 Million
2.47% of portfolio
3,635,172
Q2 2025
Reduced 14.66%
$3.06B
$38.1 Million
2.33% of portfolio
1,437,555
Q2 2025
Added 0.11%
$4.17B
$34.2 Million
2.09% of portfolio
255,048
Q2 2025
Reduced 70.17%
$9.42B
$33.3 Million
2.04% of portfolio
129,628
Q2 2025
Added 17.71%
$602M
$31.2 Million
1.91% of portfolio
3,273,349
Q2 2025
Reduced 9.61%
$943M
$26.6 Million
1.63% of portfolio
872,246
Q2 2025
Reduced 8.84%
$449M
$23.8 Million
1.46% of portfolio
1,107,770
Q4 2023
Added 4.73%
$354M
$20.1 Million
1.23% of portfolio
8,353,287
Q3 2024
Reduced 7.43%
$2.63B
$19.4 Million
1.19% of portfolio
1,121,034
Q2 2025
Reduced 32.15%
$6.14B
$18.4 Million
1.13% of portfolio
60,781
Q2 2025
Added 24.83%
$6.74B
$18 Million
1.1% of portfolio
144,556
Q2 2025
Added 77.03%
$509M
$16.8 Million
1.03% of portfolio
822,735
Q2 2025
Added 125.25%
$245B
$15.4 Million
0.94% of portfolio
49,400
Q2 2025
New
$4.73B
$14.6 Million
0.89% of portfolio
247,200
Q2 2025
New
$451M
$14.2 Million
0.87% of portfolio
2,181,598
Q2 2025
Reduced 38.32%
$463M
$13 Million
0.8% of portfolio
1,655,690
Q1 2025
Added 168.99%
$748M
$11.8 Million
0.72% of portfolio
884,306
Q3 2024
Added 71.16%
$259M
$3.93 Million
0.24% of portfolio
422,887
Q2 2025
Reduced 71.07%
$59.3M
$1.95 Million
0.12% of portfolio
752,541
Q1 2024
Reduced 4.49%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 17.74%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 4.02%
-
$0
0.0% of portfolio
-
Q2 2025
Added 3.06%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 90.01%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 48.24%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.03%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 18.6%
Karyopharm Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 43.83%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 74.83%
Ironwood Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 3.34%